AMEX
106.23USD
-3.67 (-3.34%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
43.3M
P/E
—
EPS
—
Beta
0.83
52W range
66.55-109.945
Day range
106.23–108.26
Open
108.26
Prev close
109.90
Volume
6.9K
Avg volume
10.2K
Dividend
0.07
IPO
2014-12-17
https://seekingalpha.com/article/4938856-bbp-the-biotech-etf-that-filters-for-fda-approved-drugs · 8/20/2026+0.80
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name change on February 27, transitioning from Virtus LifeSci Biotech Products ETF to its current designation.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
